Oct 4, 2026 | Events, News
We are proud to exhibit at the premier meeting of ID experts Dates: October 21-24, 2026 Location: Walter E. Washington Convention Center, Washington, DC Our team looks forward to participating again at IDWeek 2026, which will be held this year in Washington, D.C. As...
May 30, 2026 | Events, News
Healix is excited to participate as an exhibitor at the NORM 2026 Annual Conference Dates: October 1-3, 2026 Location: Hyatt Regency, New Orleans, LA The Annual Conference of the National Organization of Rheumatology Management (NORM) is taking place in New Orleans...
Dec 18, 2025 | Clinical Outcomes, News
Abstract Introduction Intravenous immune globulin 10% liquid (IVIG 10%) is used in the treatment of primary immunodeficiency (PID). Originally approved in 2012 and then voluntarily withdrawn in 2016, IVIG 10% (BIVIGAM®) underwent manufacturing process improvements by...
Dec 3, 2025 | Clinical Outcomes, News
Abstract Introduction Atherosclerotic cardiovascular disease (ASCVD) is a global health concern. Reducing low-density lipoprotein cholesterol (LDL-C) is critical in ASCVD prevention and treatment. Inclisiran, a novel RNA therapeutic agent, offers a promising solution...
Recent Comments